Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Gillett, Alan ^a   Maratou, Klio ^b   Fewings, Chris ^b   Harris, Robert A ^a   Jagodic, Maja ^a   Aitman, Tim ^b   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; POTASSIUM CHANNEL; TRANSCRIPTOME;

ALLERGIC ENCEPHALOMYELITIS; ALTERNATIVE RNA SPLICING; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXON; GENE ACTIVATION; GENE CLUSTER; GENE FUNCTION; GENE TARGETING; GENETIC SUSCEPTIBILITY; GENOME; GLYCOSYLATION; IMMUNOREGULATION; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; NONHUMAN; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; RAT; ANIMAL; CYTOLOGY; DISEASE MODEL; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATION; LYMPH NODE; LYMPHOCYTE; METABOLISM; METHODOLOGY; PATHOLOGY;

AGOUTI; ANIMALIA; RATTUS;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; INFLAMMATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

EID: 70450177731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007773     Document Type: Article

References (63)

1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372: 1502-1517.
2. Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, et al. (1997) Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol 244: 153-159.
3. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA (2006) Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180: 63-70.
4. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, et al. (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348: 15-23.
5. Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-31; discussion S43-54.
6. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, et al. (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8: 681-694.
7. Thessen Hedreul M, Gillett A, Olsson T, Jagodic M, Harris RA (2009) Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J Neuroimmunol.
8. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, et al. (2008) Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 181: 3750-3754.
9. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM (2008) Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14: 337-342.
10. Mueller AM, Pedre X, Stempfl T, Kleiter I, Couillard-Despres S, et al. (2008) Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflammation 5: 20.
11. Carmody RJ, Hilliard B, Maguschak K, Chodosh LA, Chen YH (2002) Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J Neuroimmunol 133: 95-107.
12. Ibrahim SM, Mix E, Bottcher T, Koczan D, Gold R, et al. (2001) Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124: 1927-1938.
13. Achiron A, Feldman A, Mandel M, Gurevich M (2007) Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann N Y Acad Sci 1107: 155-167.
14. Arthur AT, Armati PJ, Bye C, Heard RN, Stewart GJ, et al. (2008) Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med Genet 9: 17.
15. Avasarala JR, Chittur SV, George AD, Tine JA (2008) Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2. BMC Med Genomics 1: 2.
16. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, et al. (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39: 1108-1113.
17. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39: 1083-1091.
18. Amor S, Groome N, Linington C, Morris MM, Dornmair K, et al. (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349-4356.
19. Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, et al. (2007) ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Res 35: D747-750.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
21. Della Beffa C, Cordero F, Calogero RA (2008) Dissecting an alternative splicing analysis workflow for GeneChip Exon 1.0 ST Affymetrix arrays. BMC Genomics 9: 571.
22. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
23. Sanges R, Cordero F, Calogero RA (2007) oneChannelGUI: a graphical interface to Bioconductor tools, designed for life scientists who are not familiar with R language. Bioinformatics 23: 3406-3408.
24. Benjamini YaH, Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. JR Statist Soc 57: 289-300.
25. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
26. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
27. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
28. Benovoy D, Kwan T, Majewski J (2008) Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res 36: 4417-4423.
29. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
30. Bemmo A, Benovoy D, Kwan T, Gaffney DJ, Jensen RV, et al. (2008) Gene expression and isoform variation analysis using Affymetrix Exon Arrays. BMC Genomics 9: 529.
31. Mor A, Philips MR (2006) Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 24: 771-800.
32. Nagamatsu Y, Rikitake Y, Takahashi M, Deki Y, Ikeda W, et al. (2008) Roles of Necl-5/poliovirus receptor and Rho-associated kinase (ROCK) in the regulation of transformation of integrin alpha(V)beta(3)-based focal complexes into focal adhesions. J Biol Chem 283: 14532-14541.
33. Russo MW, Sevetson BR, Milbrandt J (1995) Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci U S A 92: 6873-6877.
34. Baillat D, Hakimi MA, Naar AM, Shilatifard A, Cooch N, et al. (2005) Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123: 265-276.
35. Chen J, Xu J, Ying K, Cao G, Hu G, et al. (2004) Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma. Gene 340: 61-69.
36. Sawadogo M, Roeder RG (1985) Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43: 165-175.
37. Gutcher I, Urich E, Wolter K, Prinz M, Becher B (2006) Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol 7: 946-953.
38. Sun D, Branum K, Sun Q (1992) Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19). Cell Immunol 145: 263-271.
39. Walter S, Fassbender K, Gulbins E, Liu Y, Rieschel M, et al. (2002) Glycosylation processing inhibition by castanospermine prevents experimental autoimmune encephalomyelitis by interference with IL-2 receptor signal transduction. J Neuroimmunol 132: 1-10.
40. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH (2005) Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A 102: 13992-13997.
41. Khademi M, Illes Z, Gielen AW, Marta M, Takazawa N, et al. (2004) T Cell Ig-and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 172: 7169-7176.
42. Wang G, Zeng J, Shen CY, Wang ZQ, Chen SD (2008) Overexpression of Kir2.3 in PC12 cells resists rotenone-induced neurotoxicity associated with PKC signaling pathway. Biochem Biophys Res Commun 374: 204-209.
43. Judge SI, Bever CT Jr (2006) Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 111: 224-259.
44. DeCoursey TE, Chandy KG, Gupta S, Cahalan MD (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307: 465-468.
45. Lee SC, Sabath DE, Deutsch C, Prystowsky MB (1986) Increased voltage-gated potassium conductance during interleukin 2-stimulated proliferation of a mouse helper T lymphocyte clone. J Cell Biol 102: 1200-1208.
46. Panyi G, Vamosi G, Bacso Z, Bagdany M, Bodnar A, et al. (2004) Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc Natl Acad Sci U S A 101: 1285-1290.
47. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, et al. (2008) EVI5 is a risk gene for multiple sclerosis. Genes Immun 9: 334-337.
48. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776-782.
49. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, et al. (2008) Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 40: 1402-1403.
50. Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, et al. (2008) Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 9: 624-630.
51. Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A, et al. (2009) CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 10: 5-10.
52. Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, et al. (2003) Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats. Eur J Immunol 33: 1907-1916.
53. Jagodic M, Becanovic K, Sheng JR, Wu X, Backdahl L, et al. (2004) An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol 173: 1366-1373.
54. Sheng JR, Jagodic M, Dahlman I, Becanovic K, Nohra R, et al. (2005) Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis. Genetics 170: 283-289.
55. Jagodic M, Marta M, Becanovic K, Sheng JR, Nohra R, et al. (2005) Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis. J Immunol 174: 918-924.
56. Jagodic M, Olsson T (2006) Combined-cross analysis of genome-wide linkage scans for experimental autoimmune encephalomyelitis in rat. Genomics 88: 737-744.
57. Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, et al. (2008) Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet 40: 546-552.
58. Monti J, Fischer J, Paskas S, Heinig M, Schulz H, et al. (2008) Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat Genet 40: 529-537.
59. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452: 423-428.
60. Behmoaras J, Bhangal G, Smith J, McDonald K, Mutch B, et al. (2008) Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility. Nat Genet 40: 553-559.
61. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, et al. (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86: 1-12.
62. Zhang BN, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. Journal of Experimental Medicine 186: 1677-1687.
63. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, et al. (1998) Role of natural killer cells and TCR-gamma-delta T cells in acute autoimmune encephalomyelitis. European Journal of Immunology 28: 1681-1688.